RT Journal Article
SR Electronic
T1 Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19009910
DO 10.1101/19009910
A1 Karen Cardwell
A1 Susan M Smith
A1 Barbara Clyne
A1 Laura McCullagh
A1 Emma Wallace
A1 Ciara Kirke
A1 Tom Fahey
A1 Frank Moriarty
A1 on behalf of the General Practice Pharmacist (GPP) Study Group
YR 2019
UL http://medrxiv.org/content/early/2019/10/25/19009910.abstract
AB Objective Limited evidence suggests integration of pharmacists into the general practice team could improve medicines management for patients, particularly those with multimorbidity and polypharmacy. This study aimed to develop and assess the feasibility of an intervention involving pharmacists, working within general practices, to optimise prescribing in Ireland.Design Non-randomised pilot studySetting Primary care in IrelandParticipants Four general practices, purposively sampled and recruited to reflect a range of practice sizes and demographic profiles.Intervention A pharmacist joined the practice team for six months (10 hours/week) and undertook medication reviews (face-to-face or chart-based) for adult patients, provided prescribing advice, supported clinical audits, and facilitated practice-based education.Outcome measures Anonymised practice-level medication (e.g. medication changes) and cost data were collected. Patient-Reported Outcome Measure (PROM) data were collected on a subset of older adults (aged ≥65 years) with polypharmacy using patient questionnaires, before and six weeks after medication review by the pharmacist.Results Across four practices, 787 patients were identified as having 1,521 prescribing issues by the pharmacists. Issues relating to potentially inappropriate or high-risk prescribing were addressed most often by the prescriber (51.8%), compared to cost-related issues (7.5%). Medication changes made during the study equated to approximately €57,000 in cost savings assuming they persisted for 12 months. Ninety-six patients aged ≥65 years with polypharmacy were recruited from the four practices for PROM data collection and 64 (66.7%) were followed up. There were no changes in patients’ treatment burden or attitudes to deprescribing following medication review, and there were conflicting changes in patients’ self-reported quality of life.Conclusions This non-randomised pilot study demonstrated that an intervention involving pharmacists, working within general practices is feasible to implement and has potential to improve prescribing quality. This study provides rationale to conduct a randomised controlled trial to evaluate the clinical and cost-effectiveness of this intervention.Strengths and limitations of this studyThis is the first study examining the role of general practice-based pharmacists in Ireland and the feasibility of evaluating this role.Integration of pharmacists was limited to four general practices, although these were diverse in terms of practice characteristics.A range of medication and patient-reported outcome measures data were collected, although because this was a pilot study there was no control group to compare these to.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://pilotfeasibilitystudies.biomedcentral.com/articles/10.1186/s40814-018-0311-7 Funding StatementThis research was supported by the Health Research Board Research Collaborative for Quality and Patient Safety Award.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesData and analytical code relating to prescribing issues is available from www.doi.org/10.5281/zenodo.3492198. https://www.doi.org/10.5281/zenodo.3492198